Author | Phenomena of interest | Questionnaire items used to assess acceptance and/or attitudes | Answers provided by the women (N/N total) |
Gerend, 201732 | Acceptance | ‘If your doctor or healthcare provider recommended it, would you agree to have this new HPV test done instead of a Pap test?’ | Yes: 55% (172*/313) No: 14% (44*/313) Undecided: 31% (97*/313) |
Jayasinghe, 201636 | Acceptance | ‘I would be willing to have an HPV test to screen for cervical cancer instead of a Pap smear.’ | Yes 79% (106/135) |
Willingness to screen with HPV testing at extended screening intervals | 3 Yearly: 61% (82/135) 5 Yearly: 31% (41/134) 10 Yearly: 10% (14/134) | ||
Ogilvie, 201334 | Acceptance | ‘I would be willing to have an HPV test to screen for cervical cancer instead of a Pap smear’ (7-point Likert scale; >4 coded as ‘intending to screen’) | 84% (826/981) intended to screen |
Saraiya, 201833 | Acceptance | ‘Which of the following cervical cancer screening options would be acceptable to you if your doctor recommended it for you?’ | HPV test alone once every 3 years: 13% (172/1309) Annual Pap test: 40% (520/1309) Pap test every 3 years: 25% (326/1309) Pap test with HPV test every 3 years: 33% (433/1309) Pap test with HPV test every 5 years: 15% (198/1309) None of the options: 15% (190/1309) |
Silver, 201531 | Understanding the screening purpose | Screening test preference | HPV Only: 8% (43/549) Pap Only: 61% (333/549) Either: 32% (173/549) |
‘If HPV test only, how much concern about not having a Pap smear?’ | None: 22% (120/548) Slight: 37% (201/548) Moderate: 30% (165/548) Severe: 11% (62/548) | ||
‘Which is more concerning’ | Abnormal Pap: 27% (146/550) HPV Positive: 9% (51/550) Equally concerning: 64% (353/550) | ||
Understanding the personal risk | 'Perceived risk of HPV' | None/Low: 90% (492/549) Moderate/High: 10% (57/549) | |
Smith, 202137 | Acceptance | ‘Having an HPV test instead of a Pap to screen for cervical cancer is acceptable to me’ | Strongly agree/ agree: 63% (3342/5336) Neutral: 16% Disagree: 11% Don’t know: 10% |
‘Receiving HPV testing starting at age 30 years is acceptable to me’ | Agree: 68% (3635/5336 total sample); 81% (2691/3342 women who would accept HPV screening) Disagree: 13% (682/5336 total sample); 8% (259/3342 women who would accept HPV screening) Neutral: 18% (981/5336 total sample); 11% (373/3342 women who would accept HPV screening) | ||
‘I would be willing to have an HPV test every 4–5 years instead of a Pap every 3 years’ | Agree: 54% (2858/5336 total sample); 74% (2472/3342 women who would accept HPV screening) Disagree: 21% (1096/5336 total sample); 11% (352/3342 women who would accept HPV screening) Neutral: 25% (1353/5336 total sample); 15% (506/3342 women who would accept HPV screening) | ||
Understanding the implication of a positive finding | ‘I think people would judge me for having HPV’ | Agree: 33% (1775/5336) Disagree: 27% (1419/5336) Neutral: 31% (1666/5336) | |
‘Having HPV would not cause me any concern about cervical cancer’ | Agree: 3% (181/5336) Disagree: 77% (4,112/5336) Neutral: 11% (569/5336) | ||
‘I would feel comfortable telling my partner if I had HPV’ | Agree: 64% (3391/536) Disagree: 13% (709/5336) Neutral: 14% (755/5336) | ||
‘Being HPV positive would not affect my relationship with my partner’ | Agree: 23% (1249/5336) Disagree: 38% (2003/5336) Neutral: 30% (1584/5336) | ||
Understanding the screening purpose | ‘What would concern you more?’ | Abnormal Pap test result: 13% (668/5336) HPV positive test result: 13% (683/5336) Equally concerning: 72% (3855/5336) | |
Thompson, 202035 | Acceptance | Willingness to receive the HPV test instead of the Pap test (5-point Likert scale) | Willing: 55% (447/812) Not willing: 45% (365/812) |
Understanding the screening purpose | ‘What worries you more’ | Abnormal HPV test: 11% (90/812) Abnormal pap test: 14% (114/812) Equally worrying: 60% (489/812) Neither: 15% (119/812) | |
HPV test benefit: Less time at doctor’s office | Yes: 74% (597/812) No: 26% (215/812) | ||
HPV test benefit: Less frequent discomfort | Yes: 70% (571/812) No: 30% (241/812) |
*These numbers were calculated from the percentage and total number (N total * percentage).
HPV, Human Papillomavirus; n, number.